Thomas G. Wiggans

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Herb Cross, as Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas G. Wiggans

Form 4 holding Director

Annexon, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
55,000
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CymaBay Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Forma Therapeutics Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

PARDES BIOSCIENCES, INC.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
31 Aug 2023
Price
$1.50
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

PARDES BIOSCIENCES, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
31 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas G. Wiggans

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .